Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock, returning 10,923.6%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 10,923.62% |
Kindly MD, Inc Warrants (KDLYW) | 9,775% |
DeFi Development (DFDV) | 4,989.91% |
Protagenic Therapeutics (PTIXW) | 2,207.69% |
Asset Entities Inc Class B Common Stock (ASST) | 1,992% |
HCM II Acquisition (HONDW) | 1,839.66% |
Kindly MD, Inc Common Stock (KDLY) | 1,725.81% |
Mobile Global Esports (MGAM) | 1,275% |
Diginex Limited Ordinary Shares (DGNX) | 1,238.26% |
TMC the metals company Inc Warrants (TMCWW) | 890.57% |
Oncology Institute (TOI) | 886.93% |
Siyata Mobile (SYTAW) | 816.44% |
Oncology Institute (TOIIW) | 675% |
Webull Corporation Warrants (BULLW) | 530.88% |
Top KingWin (WAI) | 502.34% |
Abits (ABTS) | 498.75% |
CEL-SCI (CVM) | 497.9% |
Edible Garden (EDBLW) | 430.1% |
ThredUp (TDUP) | 412.5% |
Splash Beverage Group, Inc WT (SBEV.WT) | 406.25% |
Dave Inc Warrants (DAVEW) | 405.93% |
error (ZVZZT) | 400% |
Nutex Health (NUTX) | 399.38% |
Oriental Culture Holding (OCG) | 394.12% |
Regulus Therapeutics (RGLS) | 393.13% |
